Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07336420 · ClinicalTrials.gov registry record · Phase 4
Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment
A Phase 4 study, sponsored by Theranica.
- Completed
- Registry status
- Phase 4
- Development phase
- 466
- Enrollment target
NCT07336420: Completed Phase 4 study, sponsored by Theranica.
NCT07336420 is a Phase 4 study that has completed, run by Theranica. The registered enrollment target is 466 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (10% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07336420, a Phase 4 study, has completed, sponsored by Theranica.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 466 participants
- Enrollment target
Study Summary
Among US veterans, migraine is a prevalent and disabling neurological disorder, creating a clinical need for effective treatment options. This real-world evidence (RWE) study assessed the use, effectiveness, and safety of the REN wearable for the acute treatment of migraine among veterans, with a primary focus on whether they need rescue medications following REN treatment. Findings from this study may help guide clinical decision-making as veterans and providers craft treatment plans that include non-pharmacologic options.
Primary Outcome
Proportion of treatments in which patients did not use additional prescribed medications within 2-hours following REN treatment
Interventions
- DEVICE Nerivio REN device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 466 participants |
| Start Date | 2026-01-09 |
| Est. Completion | 2026-01-30 |
| Phase | Phase 4 |
What the finished NCT07336420 record still lists
NCT07336420 is an interventional study that assigns participants to a tested intervention. The registered 466 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (10% lower).
The record links to 0 conditions, and to 1 intervention - of which Nerivio REN device is the first listed.
NCT07336420 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07336420 about?
NCT07336420 is a clinical study titled "Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment". Among US veterans, migraine is a prevalent and disabling neurological disorder, creating a clinical need for effective treatment options. This real-world evidence (RWE) study assessed the use, effectiveness, and safety of the REN wearable for the acute treatment of migraine among veterans, with a p...
What is the current status of trial NCT07336420?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 466 participants. The study started on 2026-01-09. Estimated completion is 2026-01-30.
What interventions are being tested in trial NCT07336420?
The interventions under investigation include: Nerivio REN device (DEVICE).
Who is sponsoring clinical trial NCT07336420?
This trial is sponsored by Theranica, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07336420's enrollment target sits among peer trials
466 182nd of 2000 higher than 1,819 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05312879 · 466 participants · Phase 2
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease
- NCT06917404 · 466 participants · Phase 3
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
- NCT07055165 · 466 participants · NA
Connect2Care: Prostate Cancer Education and Screenings for African American Men
- NCT07214779 · 466 participants · Phase 3
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI